BIOMAT Database Logo BIOMAT Database Logo

[Calcium antagonists and lung disease]. 1987

S Kitamura, and T Mieno, and Y Kuratomi

UI MeSH Term Description Entries
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

S Kitamura, and T Mieno, and Y Kuratomi
Calcium antagonists and renal disease.
May 1999, Kidney international,
S Kitamura, and T Mieno, and Y Kuratomi
Calcium antagonists and renal disease.
November 1998, Kidney international,
S Kitamura, and T Mieno, and Y Kuratomi
Calcium antagonists and renal disease.
December 1999, Kidney international,
S Kitamura, and T Mieno, and Y Kuratomi
[Coronary disease and calcium antagonists].
October 1979, L'union medicale du Canada,
S Kitamura, and T Mieno, and Y Kuratomi
[Hypertension, coronary disease and calcium antagonists].
January 1984, Cardiologia (Rome, Italy),
S Kitamura, and T Mieno, and Y Kuratomi
[Calcium antagonists and ischemic heart disease].
September 1996, Orvosi hetilap,
S Kitamura, and T Mieno, and Y Kuratomi
[Calcium antagonists and ischemic heart disease].
October 2005, Clinical calcium,
S Kitamura, and T Mieno, and Y Kuratomi
Calcium antagonists in cardiovascular disease.
October 1989, The British journal of clinical practice,
S Kitamura, and T Mieno, and Y Kuratomi
Calcium antagonists for cardiovascular disease.
October 1993, Drug and therapeutics bulletin,
S Kitamura, and T Mieno, and Y Kuratomi
[Calcium antagonists in Raynaud's disease].
November 1986, Ugeskrift for laeger,
Copied contents to your clipboard!